Status:
UNKNOWN
Home-based Exercise Program in Patients With the Post-COVID-19 Condition
Lead Sponsor:
University of Sao Paulo
Conditions:
Long COVID
Post-acute COVID-19 Syndrome
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
The management of the sequelae of COVID-19 is described as the next great challenge of global public health. Multiple symptoms may compose the clinical picture of these patients (eg, fatigue, dyspnea,...
Eligibility Criteria
Inclusion
- COVID-19 diagnostic history confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) or rapid antigen test (with clinical presentations of moderate to critical severity).
- Diagnosis of post-COVID-19 condition according to World Health Organization criteria.
- Present ≥1 symptoms at study admission, including dyspnea, fatigue, muscle weakness and/or musculoskeletal pain.
- Have internet access at home.
Exclusion
- Being under clinical or experimental treatment for the post-COVID-19 condition.
- Any physical disabilities that could hamper physical testing and exercise program.
- Patients with major neuropsychiatric disorders (eg, dementia or severe depression).
- Patients with chronic kidney disease who are in need of hemodialysis.
- Solid organ transplant patients.
- Complex ventricular arrhythmias, atrial fibrillation or complete heart block.
- Recent malignant neoplasm.
- Recent deep venous thromboembolism.
- Acute pulmonary embolism or pulmonary infarction.
- Uncontrolled hypertension.
- Uncontrolled type II diabetes.
- Uncontrolled vestibular disorders.
- Acute infections.
- Pregnancy.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT05360563
Start Date
May 1 2022
End Date
February 1 2024
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sao Paulo
São Paulo, Brazil, 05403-010